IBDEI07O ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3285,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,3286,0)
 ;;=N90.9^^18^216^112
 ;;^UTILITY(U,$J,358.3,3286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3286,1,3,0)
 ;;=3^Vulva/Perineum Noninflammaotory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,3286,1,4,0)
 ;;=4^N90.9
 ;;^UTILITY(U,$J,358.3,3286,2)
 ;;=^5015901
 ;;^UTILITY(U,$J,358.3,3287,0)
 ;;=A49.9^^18^217^1
 ;;^UTILITY(U,$J,358.3,3287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3287,1,3,0)
 ;;=3^Infection,Bacterial,Unspec
 ;;^UTILITY(U,$J,358.3,3287,1,4,0)
 ;;=4^A49.9
 ;;^UTILITY(U,$J,358.3,3287,2)
 ;;=^5000241
 ;;^UTILITY(U,$J,358.3,3288,0)
 ;;=B37.9^^18^217^2
 ;;^UTILITY(U,$J,358.3,3288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3288,1,3,0)
 ;;=3^Infection,Candidiasis,Unspec
 ;;^UTILITY(U,$J,358.3,3288,1,4,0)
 ;;=4^B37.9
 ;;^UTILITY(U,$J,358.3,3288,2)
 ;;=^5000624
 ;;^UTILITY(U,$J,358.3,3289,0)
 ;;=Z20.9^^18^217^3
 ;;^UTILITY(U,$J,358.3,3289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3289,1,3,0)
 ;;=3^Infection,Communicable Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3289,1,4,0)
 ;;=4^Z20.9
 ;;^UTILITY(U,$J,358.3,3289,2)
 ;;=^5062776
 ;;^UTILITY(U,$J,358.3,3290,0)
 ;;=B30.9^^18^217^4
 ;;^UTILITY(U,$J,358.3,3290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3290,1,3,0)
 ;;=3^Infection,Conjunctivitis,Viral,Unspec
 ;;^UTILITY(U,$J,358.3,3290,1,4,0)
 ;;=4^B30.9
 ;;^UTILITY(U,$J,358.3,3290,2)
 ;;=^5000586
 ;;^UTILITY(U,$J,358.3,3291,0)
 ;;=B25.9^^18^217^5
 ;;^UTILITY(U,$J,358.3,3291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3291,1,3,0)
 ;;=3^Infection,Cytomegaloviral Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3291,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,3291,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,3292,0)
 ;;=B35.9^^18^217^6
 ;;^UTILITY(U,$J,358.3,3292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3292,1,3,0)
 ;;=3^Infection,Dermatophytosis,Unspec
 ;;^UTILITY(U,$J,358.3,3292,1,4,0)
 ;;=4^B35.9
 ;;^UTILITY(U,$J,358.3,3292,2)
 ;;=^5000607
 ;;^UTILITY(U,$J,358.3,3293,0)
 ;;=A49.2^^18^217^8
 ;;^UTILITY(U,$J,358.3,3293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3293,1,3,0)
 ;;=3^Infection,Hemophilus Influenzae
 ;;^UTILITY(U,$J,358.3,3293,1,4,0)
 ;;=4^A49.2
 ;;^UTILITY(U,$J,358.3,3293,2)
 ;;=^5000238
 ;;^UTILITY(U,$J,358.3,3294,0)
 ;;=B00.9^^18^217^9
 ;;^UTILITY(U,$J,358.3,3294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3294,1,3,0)
 ;;=3^Infection,Herpesviral,Unspec
 ;;^UTILITY(U,$J,358.3,3294,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,3294,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,3295,0)
 ;;=B20.^^18^217^7
 ;;^UTILITY(U,$J,358.3,3295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3295,1,3,0)
 ;;=3^Infection,HIV
 ;;^UTILITY(U,$J,358.3,3295,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,3295,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,3296,0)
 ;;=B82.9^^18^217^10
 ;;^UTILITY(U,$J,358.3,3296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3296,1,3,0)
 ;;=3^Infection,Intestinal Parasitism,Unspec
 ;;^UTILITY(U,$J,358.3,3296,1,4,0)
 ;;=4^B82.9
 ;;^UTILITY(U,$J,358.3,3296,2)
 ;;=^5000798
 ;;^UTILITY(U,$J,358.3,3297,0)
 ;;=A49.02^^18^217^11
 ;;^UTILITY(U,$J,358.3,3297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3297,1,3,0)
 ;;=3^Infection,MRSA,Unspec Site
 ;;^UTILITY(U,$J,358.3,3297,1,4,0)
 ;;=4^A49.02
 ;;^UTILITY(U,$J,358.3,3297,2)
 ;;=^5000236
 ;;^UTILITY(U,$J,358.3,3298,0)
 ;;=A49.3^^18^217^12
 ;;^UTILITY(U,$J,358.3,3298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3298,1,3,0)
 ;;=3^Infection,Mycoplasma,Unspec Site
 ;;^UTILITY(U,$J,358.3,3298,1,4,0)
 ;;=4^A49.3
 ;;^UTILITY(U,$J,358.3,3298,2)
 ;;=^5000239
 ;;^UTILITY(U,$J,358.3,3299,0)
 ;;=B49.^^18^217^13
 ;;^UTILITY(U,$J,358.3,3299,1,0)
 ;;=^358.31IA^4^2
